- Home
- ELTX vs PETS Comparison
ELTX vs PETS Comparison
Compare ELTX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- PETS
- Stock Information
- Founded
- ELTX 2011
- PETS 1996
- Country
- ELTX United States
- PETS United States
- Employees
- ELTX N/A
- PETS N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- ELTX Health Care
- PETS Consumer Staples
- Exchange
- ELTX Nasdaq
- PETS Nasdaq
- Market Cap
- ELTX 121.7M
- PETS 62.8M
- IPO Year
- ELTX N/A
- PETS N/A
- Fundamental
- Price
- ELTX $7.84
- PETS $3.31
- Analyst Decision
- ELTX Strong Buy
- PETS Sell
- Analyst Count
- ELTX 2
- PETS 2
- Target Price
- ELTX $9.50
- PETS $3.35
- AVG Volume (30 Days)
- ELTX 54.7K
- PETS 128.9K
- Earning Date
- ELTX 08-12-2025
- PETS 08-05-2025
- Dividend Yield
- ELTX N/A
- PETS N/A
- EPS Growth
- ELTX N/A
- PETS N/A
- EPS
- ELTX N/A
- PETS 0.02
- Revenue
- ELTX N/A
- PETS $247,010,000.00
- Revenue This Year
- ELTX N/A
- PETS N/A
- Revenue Next Year
- ELTX N/A
- PETS N/A
- P/E Ratio
- ELTX N/A
- PETS $192.80
- Revenue Growth
- ELTX N/A
- PETS N/A
- 52 Week Low
- ELTX $3.34
- PETS $2.90
- 52 Week High
- ELTX $9.99
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- ELTX 57.03
- PETS 36.70
- Support Level
- ELTX $7.70
- PETS $3.20
- Resistance Level
- ELTX $8.05
- PETS $3.47
- Average True Range (ATR)
- ELTX 0.32
- PETS 0.18
- MACD
- ELTX -0.10
- PETS -0.04
- Stochastic Oscillator
- ELTX 28.92
- PETS 13.19
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.